Export

EN
FR
Tiotropium bromide
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03BB04
Indication
Chronic obstructive pulmonary disease ICD11 code: CA22
INN
Tiotropium bromide
Medicine type
Chemical agent
List type
Core
Formulations
Respiratory > Inhalation > powder: 18 µg in capsule
Respiratory > Inhalation > solution: 1.25 µg per actuation in soft mist inhaler ; 2.5 µg per actuation in soft mist inhaler
EML status history
First added in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Changed in 2025 (TRS 1064)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
aclidinium (ATC codes: R03BB05)
glycopyrronium (ATC codes: R03BB06)
umeclidinium (ATC codes: R03BB07)
Patent information
Main patents have expired but secondary patents might remain active in some jurisdictions. For more information on specific patents and license status for developing countries visit www.MedsPal.org
Wikipedia
Tiotropium bromide
DrugBank
Tiotropium bromide (Tiotropium)
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of tiotropium on the EML: - update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics.